Learnings from Allogeneic CAR-T Clinical Trials

Time: 10:35 am
day: Day Two

Details:

• Discussing patient conditioning without biologic immuno-depletion
• Outlining dosing considerations
• Evaluating cell expansion, persistence, and durability of response

Speakers: